Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan-Reference-Cited by-同舟云学术

Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan

Published:2020-07 Issue:1 Volume:146 Page:110-118
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Li Xiaochen^ORCID,Xu Shuyun,Yu Muqing,Wang Ke,Tao Yu,Zhou Ying,Shi Jing,Zhou Min,Wu Bo,Yang Zhenyu,Zhang Cong,Yue Junqing,Zhang Zhiguo,Renz Harald,Liu Xiansheng,Xie Jungang,Xie Min^ORCID,Zhao Jianping

Funder

Science and Technology Program of Hubei Province

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference28 articles.

1. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding;Lu;Lancet,2020

2. Diagnosis and treatment of adults with community-acquired pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America;Metlay;Am J Respir Crit Care Med,2019

3. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;Huang;Lancet,2020

4. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention [published online ahead of print February 24, 2020]. JAMA. https://doi.org/10.1001/jama.2020.2648.

5. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China [published online ahead of print February 28, 2020]. N Engl J Med. https://doi.org/10.1056/NEJMoa2002032.

Cited by 1809 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticoagulant use before COVID-19 diagnosis prevent COVID-19 associated acute venous thromboembolism or not: A systematic review and meta-analysis;World Journal of Methodology;2024-09-20

2. Genomic insight into COVID-19 severity in MAFLD patients: a single-center prospective cohort study;Frontiers in Genetics;2024-09-04

3. Current status and clinical outcomes of pharmacotherapies according to SARS-CoV-2 mutations in patients with mild-to-moderate COVID-19: a retrospective single center study;BMC Infectious Diseases;2024-09-03

4. Are we at dawn of the drug-coated balloons era? Current evidence, future directions, and tasks of the newly established working group of the Association of Cardiovascular Interventions;Cardiology Journal;2024-08-29

5. Establishment and validation of a dynamic nomogram to predict short-term prognosis and benefit of human immunoglobulin therapy in patients with novel bunyavirus sepsis in a population analysis study: a multicenter retrospective study;2024-08-27